MAPT and Alzheimer disease: From previous reports, increased PET tau tracer retention in CBS cases without underlying AD pathology was noted in the motor cortex, corticospinal tract, and basal ganglia contralateral to the affected body side, while the tracer retention pattern in AD is concentrated mostly in temporal and parietal cortices (55).